A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors

Clinical trial NCT06730659 · RECRUITING

Trial details

NCT number: NCT06730659
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed / Refractory Solid Tumor

Start date: 2024-04-19
Primary completion: 2027-04-18
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.